The Lateral flow device tests supply service for patients potentially eligible for COVID-19 treatments (LFD service) will continue to be commissioned as an Advanced service through 2025/26. NHS England has also confirmed the fee for provision of the service will increase to £4.10 + VAT from 1st April 2025, following a request from Community Pharmacy
Read moreFrom 1 April 2025, Progesterone micronised 200mg capsules (Gepretix®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the April 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to
Read moreLagevrio has been deleted from Part VIIIC of the April 2025 Drug Tariff. This follows confirmation from the Department of Health and Social Care (DHSC) and Specialist Pharmacy Service that all remaining supplies of Government procured COVID-19 antiviral medicine Molnupiravir 200mg capsules (Lagevrio®) expired on 31 March 2025. Lagevrio® remains available for pharmacies to order
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/03/2025) announced the following final list of price concessions for March 2025: Drug Pack size Price concession Ascorbic acid 500mg tablets 28 £36.08 Captopril 50mg tablets 56 £23.50
Read moreMHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited) Drug alert number: EL(25)A/12 Date issued: 31 March 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation,
Read moreCommunity Pharmacy England would like to remind pharmacy teams of the Appliances to be deleted from Part IX of the April Drug Tariff. Any NHS prescriptions for the following appliances dispensed from April will be disallowed by the NHSBSA. Product Additional information (size, product code etc) APPLIANCES – CATHETERS, URINARY, URETHRAL – Foley Catheter –
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status as complete pack sizes from April 2025: Cetraxal® 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Cetraxal® Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read moreFunding and other arrangements for community pharmacies for 2024/25 and 2025/26 have been finalised, with community pharmacy receiving the largest uplift in funding across the whole of the NHS. Ministers have said the uplift signals the Government’s commitment to stabilising the sector, and Government has given a firm commitment to work towards a sustainable funding
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (28/03/2025) announced the following list of price concessions for March 2025: Drug Pack size Price concession Buprenorphine 8mg sublingual tablets sugar free 7 £6.39 Calcium and Ergocalciferol tablets
Read more
